APA
Ribichini F., Romano M., Rosiello R., La Vecchia L., Cabianca E., Caramanno G., Milazzo D., Loschiavo P., Rigattieri S., Musarò S., Pironi B., Fiscella A., Amico F., Indolfi C., Spaccarotella C., Bartorelli A., Trabattoni D., Della Rovere F., Rolandi A., Beqaraj F., Belli R., Sangiorgio P., Villani R., Berni A., Sheiban I., Lopera Quijada M. J., Cappi B., Ribaldi L. & Vassanelli C. (20140616). A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). : JACC. Cardiovascular interventions.
Chicago
Ribichini Flavio, Romano Michele, Rosiello Renato, La Vecchia Luigi, Cabianca Ester, Caramanno Giuseppe, Milazzo Diego, Loschiavo Paolo, Rigattieri Stefano, Musarò Salvatore, Pironi Bruno, Fiscella Antonio, Amico Francesco, Indolfi Ciro, Spaccarotella Carmen, Bartorelli Antonio, Trabattoni Daniela, Della Rovere Francesco, Rolandi Andrea, Beqaraj Federico, Belli Riccardo, Sangiorgio Pietro, Villani Rosvaldo, Berni Andrea, Sheiban Imad, Lopera Quijada Maria Josè, Cappi Barbara, Ribaldi Licia and Vassanelli Corrado. 20140616. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). : JACC. Cardiovascular interventions.
Harvard
Ribichini F., Romano M., Rosiello R., La Vecchia L., Cabianca E., Caramanno G., Milazzo D., Loschiavo P., Rigattieri S., Musarò S., Pironi B., Fiscella A., Amico F., Indolfi C., Spaccarotella C., Bartorelli A., Trabattoni D., Della Rovere F., Rolandi A., Beqaraj F., Belli R., Sangiorgio P., Villani R., Berni A., Sheiban I., Lopera Quijada M. J., Cappi B., Ribaldi L. and Vassanelli C. (20140616). A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). : JACC. Cardiovascular interventions.
MLA
Ribichini Flavio, Romano Michele, Rosiello Renato, La Vecchia Luigi, Cabianca Ester, Caramanno Giuseppe, Milazzo Diego, Loschiavo Paolo, Rigattieri Stefano, Musarò Salvatore, Pironi Bruno, Fiscella Antonio, Amico Francesco, Indolfi Ciro, Spaccarotella Carmen, Bartorelli Antonio, Trabattoni Daniela, Della Rovere Francesco, Rolandi Andrea, Beqaraj Federico, Belli Riccardo, Sangiorgio Pietro, Villani Rosvaldo, Berni Andrea, Sheiban Imad, Lopera Quijada Maria Josè, Cappi Barbara, Ribaldi Licia and Vassanelli Corrado. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). : JACC. Cardiovascular interventions. 20140616.